Femasys gains UK approval for women's health products
ATLANTA - Femasys Inc. (NASDAQ:FEMY), a biomedical company specializing in women's health, has announced the UK regulatory approval of three of its products: the FemaSeed Intratubal Insemination ...
Femasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices
“This is another key milestone as we expand our reach to the UK following successful approval across Europe for our innovative infertility and cancer detection products.” stated Kathy Lee-Sepsick, ...
Rise in endometriosis among women: Doctors emphasis early intervention, awareness
With a significant rise in endometriosis cases among women aged 20-40, early intervention and awareness are crucial to reduce ...